New toolkit addresses clinical variability in pain therapy to help clinicians stem the opioid crisis
With over 130 people dying from opioid overdoses every day, health systems around the United States are implementing cross-functional opioid task force teams to reduce overdoses, treat dependence and addiction, and prevent iatrogenic opioid use disorder that may start while patients are receiving care.¹ To help our customers comply with the latest regulations, Wolters Kluwer, Health is launching a comprehensive toolkit for opioid taskforces in healthcare systems and pharmacy chains to address clinical variability in opioid-related pain therapy care and stem the tide of the opioid epidemic.
“Our approach to the opioid crisis targets not only patient behaviors but also care team behaviors,” said Priti Shah, Vice President, Products and Solutions, Clinical Effectiveness, at Wolters Kluwer, Health. “We need to address clinical variability at each touch point with the patient—physicians, nurses, and pharmacists—while also promoting safer opioid use among patient populations. To achieve that, care teams must be aligned in their decisions to ensure consistent care delivery across the pain therapy journey.”
The Wolters Kluwer Opioid Toolkit equips care teams and opioid task forces with solutions that span the care continuum:
At Hospitals, Clinics and Community Health Centers:
- Whether during a consultation or hospital stay, patients often start their pain therapy journey with a nurse, physician or other clinician. UpToDate® evidence-based content helps clinicians in assessing if opioids are appropriate. In 2018 alone, UpToDate topics related to opioids and pain management were consulted by clinicians over 4.5 million times.
- A new UpToDate® Pathway helps clinicians calculate a Morphine Milligram Equivalent (MME) (and independently review the basis of such calculation) for oral opioids and transdermal fentanyl. In addition, the UpToDate® Pathway assists clinicians in using the MME as one factor when assessing a patient’s risk for a potential opioid overdose and need for additional monitoring and safeguards (e.g., naloxone).
At Retail or Hospital Pharmacies:
- When a clinician determines opioids are warranted, a patient’s next step in the pain therapy journey is at the pharmacy, either at a hospital or within the patient’s community. Pharmacists preparing prescriptions consult Lexicomp® to check for opioid medication dosing.
- The new Medi-Span® CNS Depressant Interactions data helps prescribers and pharmacists check for high-risk opioid interactions that could affect the central nervous system, including the dangerous combination of opioids, benzodiazepines, and central muscle relaxants. With additional Medi-Span drug data integrated within the pharmacy management system, pharmacists may also screen the script for MME calculations, State and Federal DEA codes, and potential precautions or contraindications with warning labels.
- A consistent, supportive dialogue with care teams about safe opioid use must be part of the patient’s pain therapy journey. Back at home however, a patient may feel vulnerable without the support of care professionals nearby. To extend the reach of that support, the Emmi® Opioid Appropriate Use solution helps educate patients with interactive programs that guide them along a healthy path for pain management. In surveys, patients said that Emmi opioid multimedia programs helped them be more informed, discover unknown risks, and make better decisions, thus empowering them to engage in healthier behaviors that enable them to resume activities of daily living.
KLAS Recommends a Multifaceted, Toolkit Approach
In a recent KLAS study, How are Providers Tackling the Opioid Epidemic?, only seven out of 112 providers surveyed characterized their efforts to foster appropriate and safe usage as “advanced,” with multiple technologies and strategies, in place. The KLAS survey concluded “Advanced organizations report that a multifaceted approach – consisting of internal rules, technology partners, alternative treatment options, electronic prescriptions for controlled substances, and proper legislation – is necessary for effective opioid stewardship. Organizations that take such an approach have realized gains in their fight against opioid misuse.”2
The Wolters Kluwer Opioid Toolkit is complemented by Sentri7® which provides hospital systems with real-time clinical surveillance technology for the inpatient setting to help hospitals monitor and prevent adverse drug events related to opioid use.
To learn more about the Opioid Toolkit solution, please visit https://go.wolterskluwer.com/Opioid-Toolkit.html.
¹ National Institute on Drug Abuse, 'Opioid Overdose Crisis', National Institute on Drug Abuse, [Website], https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis, (accessed May 2, 2019).
2 KLAS Research, 'Opioid Management Perception 2018: EMR Vendors Being Pushed to Center Stage', KLAS Research, [Website], https://klasresearch.com/report/opioid-management-perception-2018/1346, (accessed May 2, 2019).
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global provider of professional information, software solutions, and services for physicians, nurses, accountants, lawyers, tax specialists, and finance, audit, compliance, and regulatory sectors.
The company provides expert solutions - a combination of deep domain knowledge with specialized technology and services - that help professionals navigate change, solve complex problems, and deliver impact in their respective fields.
Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer holds market-leading positions in 40 countries globally, represents customers across 180 countries and employs 18,600 people worldwide. In 2018, it reported annual revenues of €4.3 billion.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.